Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
Biotech Reimagined: From Capital Constraints to Scientific Momentum at the 2026 Yale Innovation Summit
Aegis Ventures and Yale Spinout Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
The Yale Innovation Summit's 2026 Arts Track: Where Access, Experimentation, and Creative Power Collide